Back
Insight Molecular Diagnostics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
62
IMDX
Insight Molecular Diagnostics, Inc.
Last Price:
$6.51
Seasonality Move:
9.95%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.Insight Molecular Diagnostics, Inc. Stock Forecast
-
Over the next 52 weeks, Insight Molecular Diagnostics, Inc. has on average historically fallen by 0.3% based on the past 10 years of stock performance.
-
Insight Molecular Diagnostics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Insight Molecular Diagnostics, Inc. Stock Undervalued?The current Insight Molecular Diagnostics, Inc. [IMDX] share price is $6.52. The Score for IMDX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
IMDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Insight Molecular Diagnostics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Insight Molecular Diagnostics, Inc. has on average historically fallen by 0.3% based on the past 10 years of stock performance.
Insight Molecular Diagnostics, Inc. Stock Rating
Buy
62
Insight Molecular Diagnostics, Inc. (IMDX)
is a Buy
Is Insight Molecular Diagnostics, Inc. overpriced?
-
Insight Molecular Diagnostics, Inc. has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Insight Molecular Diagnostics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncocyte.com
52-Week Data
52-Week High:
8.51
52-Week Low:
1.95
Prediction Charts
Market Cap:
186.9M
Price in USD:
6.52
Volume:
39.9K
Beta:
1.75
Technical Analysis
SMA50:
6.30
SMA100:
5.22
SMA200:
4.06
52-Wk Change:
224.38%
Stock Predictions
-
Is Insight Molecular Diagnostics, Inc. stock public?Yes, Insight Molecular Diagnostics, Inc. is a publicly traded company.
-
What is the Insight Molecular Diagnostics, Inc. stock quote today?The Insight Molecular Diagnostics, Inc. stock price is 6.52 USD today.
-
How to buy Insight Molecular Diagnostics, Inc. stock online?You can buy Insight Molecular Diagnostics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-5 | 7.14 | 7.47 | 7.51 | 7.08 |
| Jan-6 | 7.41 | 7.39 | 7.47 | 7.21 |
| Jan-7 | 7.47 | 7.50 | 7.51 | 7.25 |
| Jan-8 | 7.50 | 7.50 | 7.51 | 7.35 |
| Jan-9 | 7.50 | 7.44 | 7.50 | 7.02 |
| Jan-12 | 7.44 | 7.11 | 7.44 | 6.85 |
| Jan-13 | 7.10 | 7.23 | 7.35 | 6.86 |
| Jan-14 | 7.27 | 6.85 | 7.27 | 6.59 |
| Jan-15 | 6.93 | 6.62 | 6.94 | 6.55 |
| Jan-16 | 6.61 | 6.64 | 7.15 | 6.47 |
| Jan-20 | 6.44 | 6.15 | 6.79 | 6.05 |
| Jan-21 | 6.15 | 6.51 | 6.58 | 6.14 |
| Jan-22 | 6.56 | 6.68 | 6.86 | 6.32 |
| Jan-23 | 6.74 | 6.52 | 6.74 | 6.04 |
Insight Molecular Diagnostics, Inc. Earnings
Insight Molecular Diagnostics, Inc. Earnings Report: Per Share Insight Molecular Diagnostics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Insight Molecular Diagnostics, Inc. Forecast Revenue Growth
Insight Molecular Diagnostics, Inc. Stock Analysis: Historical quarterly revenues per share for Insight Molecular Diagnostics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.00 per share.
* Insight Molecular Diagnostics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.